Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Evogene Ltd. Major Shareholding Notification 2020

Sep 1, 2020

6785_mrq_2020-09-01_225f8b42-58a4-424d-9e5d-073f95f01a4d.zip

Major Shareholding Notification

Open in viewer

Opens in your device viewer

SC 13G 1 ea126301-sc13galpha_evogene.htm SCHEDULE 13G

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(AMENDMENT NO. ___)

EVOGENE LTD.

Field: Rule-Page

Field: /Rule-Page

(Name of Issuer)

ORDINARY SHARES, PAR VALUE NIS 0.02 PER SHARE

Field: Rule-Page

Field: /Rule-Page

(Title of Class of Securities)

M4119S104

Field: Rule-Page

Field: /Rule-Page

(CUSIP Number)

September 1, 2020

Field: Rule-Page

Field: /Rule-Page

(DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(c)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the

disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

(Continued on following page(s)

Page 1 of 5 Pages

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

CUSIP No. M4119S104 13G Page 2 of 5 Pages

  1. NAMES OF REPORTING PERSON

S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

Alpha Capital Anstalt

Field: Rule-Page

Field: /Rule-Page

  1. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:

(a) ☐

(b) ☐

Field: Rule-Page

Field: /Rule-Page

  1. SEC USE ONLY

Field: Rule-Page

Field: /Rule-Page

  1. CITIZENSHIP OR PLACE OF ORGANIZATION

Liechtenstein

Field: Rule-Page

Field: /Rule-Page

  1. SOLE VOTING POWER, NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON – 1,764,706 Ordinary Shares (1)

Field: Rule-Page

Field: /Rule-Page

  1. SHARED VOTING POWER - None

Field: Rule-Page

Field: /Rule-Page

  1. SOLE DISPOSITIVE POWER – 1,764,706 Ordinary Shares (1)

Field: Rule-Page

Field: /Rule-Page

  1. SHARED DISPOSITIVE POWER – None

Field: Rule-Page

Field: /Rule-Page

  1. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON -

1,764,706 Ordinary Shares (1)

Field: Rule-Page

Field: /Rule-Page

  1. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES

CERTAIN SHARES ☐

Field: Rule-Page

Field: /Rule-Page

  1. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

5.58%

Field: Rule-Page

Field: /Rule-Page

  1. TYPE OF REPORTING PERSON

CO

Field: Rule-Page

Field: /Rule-Page

(1) Based on 31,636,650 Ordinary Shares outstanding as of September 1, 2020.

Field: Page; Sequence: 2

Field: /Page

CUSIP No. M4119S104 13G Page 3 of 5 Pages

ITEM 1 (a) NAME OF ISSUER: Evogene Ltd.

ITEM 1 (b) ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES:

13 Gad Feinstein Street, Park Rehovot P.O.B 2100, Rehovot 7612002, Israel

ITEM 2 (a) NAME OF PERSON FILING: Alpha Capital Anstalt

ITEM 2 (b) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:

Lettstrasse 32, FL-9490 Vaduz, Furstentums, Liechtenstein

ITEM 2 (c) CITIZENSHIP: Liechtenstein

ITEM 2 (d) TITLE OF CLASS OF SECURITIES: Ordinary Shares, par value NIS 0.02

ITEM 2 (e) CUSIP NUMBER: M4119S104

ITEM 3 IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B) OR 13D-2(B): Not applicable

ITEM 4 OWNERSHIP

(a) AMOUNT BENEFICIALLY OWNED: 1,764,706 Ordinary Shares (1)

(b) PERCENT OF CLASS: 5.58%

(c) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:

(i) SOLE POWER TO VOTE OR DIRECT THE VOTE

1,764,706 Ordinary Shares (1)

(ii) SHARED POWER TO VOTE OR DIRECT THE VOTE

0 Shares

(iii) SOLE POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF

1,764,706 Ordinary Shares (1)

(iv) SHARED POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF

0 Shares

Field: Page; Sequence: 3

Field: /Page

CUSIP No. M4119S104 13G Page 4 of 5 Pages

ITEM 5 OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

Not applicable

ITEM 6 OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON

Not applicable

ITEM 7 IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY

Not applicable

ITEM 8 IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF A GROUP

Not applicable

ITEM 9 NOTICE OF DISSOLUTION OF GROUP

Not applicable

Field: Page; Sequence: 4

Field: /Page

CUSIP No. M4119S104 13G Page 5 of 5 Pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

September 1, 2020
(Date)
/s/ Konrad Ackermann
(Signature)
Konrad Ackermann, Director
(Name/Title)

Field: Rule-Page

Field: /Rule-Page